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The mechanisms of commitment and differentiation of hemopoietic stem cells are 
at present not known.  Some evidence suggests that erythropoietin can act directly at 
the level of the stem cell (1) resulting in commitment to differentiation but proof that 
any hormone  or stimulatory factor acts specifically and  directly on  the pluripotent 
stem  cell  is  lacking.  Recently  Till  (2)  proposed  a  model  in  which  stem  cells  are 
characterized  by  a  multiplicity of surface  markers  and  suggested  that  particular 
markers may be restricted to a  single pathway of differentiation. Furthermore,  as a 
means of reconciling various models for the induction of stem cell differentiation, it 
was  suggested that  pluripotent  stem  cells express low concentrations  of cell surface 
markers  which  increase  in  numbers  as  differentiation  proceeds,  a  process  which 
parallels surface marker restriction to a  particular pathway of differentiation. 
We  have  tested  this  model with  respect  to  cell surface  markers  held  in  common 
between mature hemopoietic cells and the stem cells from which they were derived. 
Platelets, thymocytes, and  macrophages  each  express antigens in common  with  the 
pluripotent stern cell (colony-forming unit), whereas erythrocytes appear to be devoid 
of such  antigens  (3).  In  the present  paper we have  characterized the anti-stem cell 
activity in antisera against CBA mouse platelets, thymocytes, and macrophages using 
quantitative  absorption  and  show  that  this  activity  is  restricted  to  a  particular 
hemopoietic cell type  (cell-lineage-specific), is tissue specific and species specific but 
common to both the inbred and randomly bred mouse strains tested. 
Materials  and  Methods 
Animals.  CBA T6/T6  mice  (2-3  too) were  bred at  Victoria University and  used in  the 
preparation of antisera and for erythrocyte absorptions. C57B1/6  mice were bred at Victoria 
University whereas  BALB/c and  NH1/A  mice were bred at  the  National  Health  Institute, 
Wellington, New Zealand. CFx mice were from SPF stock bred at Wallaceville  Animal Research 
Centre, Upper Hutt, New Zealand. CBA mice were used as donors and CBA  ×  C57B1 mice 
(2-3 mo) were used as recipients in the spleen colony assay. New Zealand white rabbits were 
used for raising antisera and for relevant absorptions. Randomly bred albino rats of Wistar and 
Sprague Dawley origin were used to prepare cells for absorption, whereas human thymocytes 
were obtained from a 4-mo-old male child who died of asphyxia 18 h before cell preparation. 
Preparation of  Antisera.  Antisera against CBA mouse platelets, thymocytes, and macrophages 
were prepared according to Gozzo et al. (4) by injecting rabbits with 2-3  ×  10  7 nucleated cells 
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or 1-2 ×  109 platelets homogenized with complete Freund's adjuvant at multiple subcutaneous 
and intramuscular sites. 4-5 wk later, the animals were given intravenous booster injections on 
three consecutive days with a similar number of cells.  1 wk later, the rabbits were bled and the 
antisera heated at 56°C for 30 min and stored at -  17°C. Before the assay or further absorptions, 
all  antisera  were  absorbed  with  an  equal  volume of CBA  erythrocytes  at  4°C  for  1  h. 
Erythrocyte absorption was routinely used with all antisera because it  has previously been 
shown that antisera against CBA mouse erythrocytes when appropriately absorbed with other 
hemopoietic cells does not cross-react  with the pluripotent stem cell (3). 
Cell Preparation and Absorption.  Mouse iso-osmotic-buffered balanced salt solution (mSBSS, 
5) 1 was used throughout. Hemopoietic cells were prepared as described previously (3). Macro- 
phages used for absorption were obtained from peritoneal washes of G75 Sephadex (Pharmacia 
Fine Chemicals,  Div.  of  Pharmacia  Inc.,  Piscataway,  N.  J.)-stimulated  mice  or  rats  and 
contained 80-90% monocyte-macrophage cells as determined by staining with methylene blue/ 
acetic acid, latex bead uptake, and carbonyl iron uptake.  For the preparation of antisera, 
maerophages were further purified by adherence to plastic Petri dishes  (3). 
Absorptions were carried out on neat antisera at 4°C for  1 h with packed volumes of tissue 
or cells  that  had  been washed three times in mSBSS. Calculations of the cell  surface area 
involved in various absorptions were based on the observation that  1 ml packed cell volume 
contained 7.3  ×  l0  s macrophages, 3  ×  109 thymocytes, 10  x° erythrocytes, and 1011 platelets. 
Assuming maerophages and thymocytes to have average Diam of 15/~m and 8/~m, respectively 
(6), erythrocytes to have a surface area of 140 ~m  2 (7) and platelets 14 pm  2 (8), the total cell 
surface area of 1 ml packed cell volume of macrophages is 5.2  ×  10  aa/~m  2, thymocytes 6.0  × 
10  ix pm  ~, erythrocytes 14  ×  1011 #m  2, and platelets 14  ×  10  xa pm  2. Thus, the differences in 
surface area of the cells used for absorption would have affected the comparative quantitative 
absorption results in Fig.  3  by little more than one serial dilution. Differences in cell  size 
between mouse, rat, rabbit, and man would also have a small effect on quantitative absorption 
results but comparative figures for these calculations are not readily available. 
Spleen Colony Inhibition Assay.  The method of Till and McCulloch (9) was used to measure 
viable pluripotent stem cells after treatment of bone marrow cells with antiserum. Bone marrow 
cells (2.5-3.0 ×  107/ml, 0.075 ml) purified on Isopaque-Ficoll (p =  1.09; [3]; Isopaque [sodium 
metrizamide], Wyegaard & Co.,  Oslo,  Norway;  Ficoll, Pharmacia Fine Chemicals, Div. of 
Pharmacia, Inc.) were incubated for at least 30 min at 4°C with 0.075 ml of antiserum diluted 
in  mSBSS.  Immediately before  injection (within  3  h  of mixing cells  and  antiserurh)  the 
antibody-treated cells  were diluted  120-fold and 5  ×  104 nucleated cells  in 0.4  ml mSBSS 
injected into each of five mice that had been lethally irradiated (900 rad, 300 rad/min) within 
6  h  of injection. Spleen colonies were counted after 8  d.  The serum titer is defined as  the 
dilution of antiserum (per unit volume) that gives a 50% inhibition of spleen colony formation 
and was obtained from the cytotoxic curve. All serum dilutions represent the final dilution of 
antiserum in the presence of cells. 
Results 
Anti-Stem  Cell Activity  in Antisera against CBA  Mouse,  Platelets,  Thymocytes,  and Macro- 
phages.  Antisera raised  in  rabbits  against  CBA  mouse  platelets,  thymocytes  and 
macrophages and absorbed with erythrocytes cross  reacted  with  hemopoietic stem 
cells obtained from the bone marrow of CBA mice. Fig.  1 shows the titration curves 
of each  antiserum against  stem  cells  as  measured  by  inhibition of spleen  colony 
formation in lethally irradiated mice. The titers of each antiserum were: anti-platelet 
serum  7131,  anti-thymocyte serum  2574,  and  anti-macrophage serum  2272.  With 
increasing concentration each antiserum killed between 92 and 98% of stem cells. 
Tissue Specificity of Anti-Stem  Cell Activity in Antisera.  Neat  antisera that  had been 
absorbed with an equal volume ofCBA erythrocytes were used for further absorptions 
1  Abbreviation used in this paper: mSBSS, mouse iso-osmotic-buffered  balanced salt solution. M.  V.  BERRIDGE  979 
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FIG.  1.  Anti-stem cell  activity in antisera against mouse platelets, thymocytes, and macrophages. 
Bone marrow cells  were treated  in  vitro with antiserum before injection  into lethally  irradiated 
mice. A. anti-platelet serum, B. anti-thymoeyte serum, C. anti-macrophage serum. The arrow shows 
the concentration at which each antiserum was used in subsequent experiments. This varied between 
12 and 16 times the 50% titer of the antiserum and routinely gave >85% loss of spleen colonies with 
erythrocyte-absorbed antisera. 
and absorbed antisera were tested for anti-stem cell activity at ~ 16 times their titer 
for stem cells  (see arrow in Fig.  1). Absorption of each antiserum with tissues other 
than those used to prepare the antiserum, for example, brain, kidney, liver, and testis, 
had  little effect on anti-stem cell activity  (Fig.  2).  With  four volumes of absorbing 
liver or kidney  tissue  ~25%  of the  anti-stem  cell  activity was  removed  from anti- 
platelet serum. Similarly liver absorption removed  18% of the anti-stem cell activity 
from anti-thymocyte serum and ~9% of the anti-stem cell activity in anti-macrophage 
serum. 980 
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Ftc.  2.  Anti-stem  cell activity in antisera absorbed with CBA mouse tissues. Bone marrow cells 
were treated with antisera that had been absorbed with brain  (C)), kidney (0),  liver (A), or testis 
(A) from CBA mice, before injection into lethally irradiated mice. A. anti-pLatelet serum, B. anti- 
thymocyte serum, C. anti-macrophage serum. The average standard error is shown to the right of 
each graph. In the absence of antiserum the average spleen colonies were 22.2 --- 1.5. 
With each absorbing tissue there was a  minimum ninefold difference in absorbing 
capacity between the particular  tissue and the homologous cell type used to prepare 
the antiserum. 
Cell-Lineage-specificity of Anti-Stem  Cell Activity  in Antisera.  Quantitative  absorption 
was  used  to  investigate  the  degree  to  which  antigens  held  in  common  between 
differentiated hemopoietic cells and stem cells are specific for a particular cell lineage. 
If antigens  that  cross  react  with  stem  cells  are  present  in  significant  quantities  on 
more  than  one  differentiated  hemopoietic  cell  type,  then  this  activity  would  be 
demonstrated as a loss of anti-stem cell activity after absorption with the cross-reacting 
cell type. Fig.  3 shows the results of quantitative  absorptions of each antiserum  with 
various  hemopoietic  cell  types.  Neither  thymocytes  nor  macrophages  removed  a 
significant  proportion  of the  anti-stem  cell  activity  in  anti-platelet  serum  whereas 
absorption with  1 volume of homologous platelets completely removed the anti-stem 
cell  activity  (Fig.  3A).  Absorption  of anti-thymocyte serum  with  peritoneal  macro- 
phages (Fig. 3 B) removed 65% of the anti-stem cell activity at a 4-volume absorption. 
A plateau was not obtained with this absorption. Absorption of anti-thymocyte serum 
with  platelets  resulted  in  a  33%  loss  of anti-stem  cell  activity  at  plateau  values, 
whereas  absorption with homologous thymocytes completely removed anti-stem  cell 
activity. 
With anti-macrophage serum  (Fig. 3 C) thymocyte absorption did not reduce anti- 
stem  cell  activity whereas  platelets  removed  ~25%  of the  anti-stem  cell  activity,  a 
figure which appeared  to reach a  plateau  at  1 volume of absorbing platelets.  Again, 
homologous macrophage absorption  removed all  of the  anti-stem  cell  activity from 
anti-macrophage serum. M.  V.  BERRIDGE  981 
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Flo.  3.  Anti-stem cell  activity in antisera absorbed with CBA mouse platelets, thymoeytes, and 
macrophages. Bone marrow cells were treated with antisera that had been absorbed with platelets 
(A), thymocytes (O), or macrophages (©)  from CBA mice, before injection into lethally irradiated 
mice. A.  anti-platelet  serum, B.  anti-thymocyte serum, C.  anti-macrophage serum. The average 
standard error is shown to the right of each graph. In the absence of antiserum the average spleen 
colonies were 22.8  -  1.2. 
The  small  (25-33%)  loss  of anti-stem  cell  activity  in  anti-thymocyte and  anti- 
macrophage serum after absorption with platelets was not associated with a reciprocal 
loss of anti-stem cell activity after absorption of anti-platelet serum with thymocytes 
and macrophages. 
Mouse Strain Specificity of Anti-Stem Cell Activity  in Antisera.  The presence of common 
cell-lineage-specific antigens on the hemopoietic cells of different mouse strains was 
investigated by quantitative absorption of each antiserum with  homologous hemo- 
poietic cells from various mouse strains. Of five mouse strains tested (i.e., CBA, C57B1, 
BALB/c,  NH1/A,  and  CF])  hemopoietic cells  from  each  were  able  to  completely 
remove the anti-stem cell activity in antisera against CBA mouse platelets or thymo- 
cytes (Figs.  4A and B). With anti-macrophage serum, absorption with macrophages 
from mouse strains other than CBA resulted in 61-72% loss of anti-stem cell activity 
at plateau values (Fig. 4C). 
Although quantitative differences in absorbing capacity were observed between the 
different mouse strains,  these differences did  not  vary by more than  2.5-fold for a 
particular antiserum. 
The results show cross reacting cell-lineage-specific antigens to be present on both 
the inbred (H2  u, H2  b, and H2  d) and outbred strains tested. 
Species Specificity  of Anti-Stem  Cell  Activity  in  Antisera.  The  degree to  which  cell- 
lineage-specific antigens on mouse hemopoietic cells cross-react with hemopoietic cells 
from other species such as rat, rabbit, and human is shown in Fig. 5. No loss of anti- 
stem  cell  activity was  observed after absorption of antiserum  against  CBA  mouse 
platelets with  platelets  from other species.  Thus,  a  minimum  16-fold difference in 
absorbing capacity is evident between CBA mouse platelets and platelets from the 982  CELL-LINEAGE-SPECIFIC  ANTIGENS  ON  HEMOPOIETIC  STEM  CELLS 
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FIG.  4.  Anti-stem cell activity in antisera absorbed with homologous hemopoietic cells from various 
mouse strains.  Bone  marrow  cells were  treated  with  antisera  that  had  been  absorbed  with  the 
appropriate hemopoietic cells against which each antiserum had been raised, before injection into 
lethally irradiated mice. Absorbing cells were obtained from CBA/T6T6 (A), C57B1/6 (O), BALB/ 
c  (m),  NH1/A  (&),  or  CF1  (0)  mice.  A.  anti-platelet  serum  absorbed  with  platelets,  B.  anti- 
thymocyte serum absorbed with thymocytes, C. anti-macrophage serum absorbed with macrophages. 
The average standard error is shown to the right of each graph. In the absence of antiserum the 
average spleen colonies were 22.3  ±  1.I. 
other species  tested.  With  anti-thymocyte serum,  both  rat  and  rabbit  thymocytes 
produced a small loss of anti-stem cell activity (33 and 21%,  respectively) with 4 vol 
of absorbing cells, whereas no reduction in anti-stem cell activity was observed after 
absorption with human thymocytes. Rat macrophages resulted in some (39%) loss of 
anti-stem cell activity in anti-macrophage serum. Difficulties in obtaining sufficient 
quantities  of rabbit  and  human  macrophages  have  limited  our  analysis  of anti- 
macrophage serum. 
Discussion 
The  antigenic  analysis  of hemopoietic  cells,  in  particular  of lymphocytes, has 
centered around investigation of the acquisition of cell surface determinants that are 
not  demonstrably  present  at  earlier stages  of differentiation  (10,  11). Collectively, 
these antigens which arise in the mature animal as a result of differentiation processes 
have been termed differentiation antigens. Although knowledge of these antigens has 
proven to be of considerable value in functionally defining subpopulations of differ- 
entiated cells, the role of most of these antigens has yet to be elucidated. In contrast 
to differentiation antigens, we present evidence for a  group of cell surface antigens, 
termed cell-lineage-specific antigens,  that appear to be selectively conserved during 
differentiation. That this class of antigens is fundamentally distinct from differentia- 
tion antigens is indicated by the absence of antigens such as Ia  (12,  13),  FcR  (14), 
Thy-1  and  Ig  (M.  V.  Berridge, unpublished  observations)  from hemopoietic stem 
cells. Furthermore, cell-lineage-specific antigens appear to be distinct from histocom- ! 
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Fro. 5.  Anti-stem cell activity in antisera absorbed with homologous hemopoietic cells from various 
species. Bone marrow cells were treated with antisera that had been absorbed with the appropriate 
hemopoietic  cells against  which  each  antiserum  had  been  raised  before  injection  into  lethally 
irradiated mice. Absorbing cells were obtained from CBA mouse  (O), rat  (Q), rabbit (A), and 
human (&). A. anti-platelet serum absorbed with platelets, B. anti-thymocyte serum absorbed with 
thymocytes, C. anti-macrophage serum absorbed with macrophages. The average standard error is 
shown at the right of each graph. In the absence of antiserum  the average spleen colonies were 18.2 
+  1.9. 
patibility antigens which  are  thought  to  be present  on  most  cells, in  that  they  are 
largely restricted to  a  certain pathway of differentiation  (Fig.  3).  For example, the 
anti-stem cell activity in  anti-platelet serum  was  not  removed  by absorption  with 
either thymocytes or macrophages. The small (25-33%)  loss of anti-stem cell activity 
in anti-thymocyte and anti-macrophage serum after absorption with platelets may be 
a true cross reaction because the loss of anti-stem cell activity reached a  plateau value 
at  1 volume of absorbing cells, a  result that  would not  have been expected if white 
cell  contamination  of absorbing  platelets were  the  responsible  factor.  In  contrast, 
macrophage absorption of anti-thymocyte serum resulted in increasing losses of anti- 
stem cell activity. This pattern of absorption is consistent with  thymocyte contami- 
nation of absorbing macrophages. Quantitation of the difference in absorbing capacity 
between  macrophages and homologous thymocytes for the anti-stem cell activity in 
anti-thymocyte serum showed a 4.2-fold difference, a  result which closely corresponds 
to the fraction of small lymphocytes observed in cell preparations from G75 stimulated 
peritoneal  washes  (Materials  and  Methods).  Conversely,  thymocyte  absorption  of 
anti-macrophage serum did not result iri significant loss of anti-stem cell activity. The 
fact that homologous absorptions removed all anti-stem cell activity at between  1 and 
2 volumes of absorbing cells suggests that the anti-stem cell activities observed in the 
various antisera were  not  a  result  of minor cell populations  in  the  inoculating cell 
type.  Furthermore,  the  evidence  indicates  that  most  (92-97%)  of the  stem  cells in 
bone  marrow  express antigens that  cross-react with  each  of the cell-lineage-specific 
antisera tested (see also Fig.  1). 984  CELL-LINEAGE-SPECIFIC  ANTIGENS  ON  HEMOPOIETIC  STEM  CELLS 
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Fro.  6.  Model of the major classes of cell surface antigens on hemopoietic cells. H2  represents 
histocompatibility antigens expressed on  all  hemopoietic cells;  D~,  Dm,~, DT,  and  D1,  represent 
differentiation antigens  expressed on  differentiating and  mature  blood  cells;  E,  m~,  T,  and  P 
represent  cell-lineage-specific antigens  expressed  on  hemopoietic  stem  cells  and  on  respective 
differentiating cell lines. Such antigens are apparently lost after enucleation and terminal differen- 
tiation  of the erythrocyte. Brain  and sperm represent antigens present on these nonhemopoietic 
tissues that cross-react with the hemopoietic stem cell (I5, 16). 
A model showing the presence of cell-lineage-specific antigens on hemopoietic cells 
is  shown  in  Fig.  6.  Cell-lineage-specific  antigens  are  shown  to  be  distinct  from 
differentiation antigens  (present only on differentiating cells) and from histocompat- 
ibility antigens (present on all hemopoietic cells). The stage of differentiation at which 
antigens held in common between stem cells and differentiated cells become restricted 
to a  particular pathway of differentiation is not known but cell membrane turnover 
and  antigen  dilution  through  membrane  synthesis  required  for  cell  division  may 
quickly result in the loss of a  group of antigens at an early stage of commitment and 
differentiation.  In terms of the model proposed by Till (2)  we have not been able to 
demonstrate antigens on erythrocytes (3) or reticulocytes (M. V. Berridge, unpublished 
observations)  that cross-react with stem cells.  In addition,  spleen cells from phenyl- 
hydrazine-treated  mice  which  contained  >95%  nucleated  erythrocyte  precursors 
exhibited only weak antigenic cross reactivity with stem cells (titer 64).  Even so, our 
results indicate that there is greater anti-stem cell activity in antisera against nucleated 
erythrocytes precursors than  in antisera against  the more mature enucleated  eryth- 
rocytes and reticulocytes, and justify the inclusion of an erythroid cell-lineage antigen 
on the pluripotent stem cell in the model presented in Fig. 6. 
The  extent  to  which  cell-lineage-specific  antigens  are  quantitatively  conserved 
during  differentiation  remains  unclear.  Because  stem  cells  comprise  only  a  small 
fraction  of bone  marrow cells  and  cannot  be  morphologically identified,  it  is  not M.  V. BERRIDGE  985 
possible to  determine  the number of antibody molecules bound  to stem cells.  Fur- 
thermore,  there  is  no  obvious  way  of  determining  the  number  of  antigens  on 
differentiated cells that cross-react with stem cells.  Thus, we have not  been able to 
show whether antigens characteristic of a particular hemopoietic cell lineage increase 
their cell surface concentration as differentiation proceeds as suggested by Till (2). 
In addition to showing cell-lineage-specificity, antisera against CBA mouse platelets, 
thymocytes and macrophages were also shown to be tissue specific and species specific, 
although  rat thymocytes and macrophages showed some ability to absorb the anti- 
stem cell  activity  in  their  respective antisera  against  CBA  mouse cells  (Fig.  5).  In 
contrast, homologous hemopoietic cells from all mouse strains tested readily absorbed 
all of the anti-stem cell activity in anti-platelet serum and anti-thymocyte serum and 
most (61-72%) of the anti-stem cell activity and anti-macrophage serum. The reason 
why macrophages from mouse strains other than CBA absorbed <100% of the anti- 
stem cell activity in antiserum against CBA macrophages is not known, but the results 
suggest  a  small  group of cell-lineage-specific antigens  on CBA mouse macrophages 
that are not present in significant amounts in other mouse strains. Therefore, results 
are in general agreement with previously reported experiments (3) where bone marrow 
stem  cells  from  C57B1  and  BALB/c  mice  were  shown  to  be  sensitive  to  antisera 
against  CBA  mouse platelets,  thymocytes and  macrophages and  confirm  that  cell- 
lineage-specific antigens are common to a  variety of mouse strains. 
The possibility that cell-lineage-specific antigens may be involved in commitment 
of the pluripotent  stem cell to a  particular pathway of differentiation  and  that  the 
presence  of  these  antigens  may  be  required  for  continued  differentiation  is  an 
attractive hypothesis that is presently under investigation. 
Summary 
A new class of cell surface antigens are described which are expressed on cells within 
a  particular  differentiation  pathway.  These  antigens,  termed  cell-lineage-specific 
antigens, are shown to be distinct  from differentiation antigens and from histocom- 
patibility  antigens.  The  presence  of these  antigens  was  demonstrated  by  raising 
antisera against terminally differentiated hemopoietic ceils such as platelets, thymo- 
cytes, and  macrophages and  showing cross-reaction with  the pluripotent  stem cells 
from which these cells were derived. Quantitative absorption studies of each antiserum 
showed the antigens to be largely cell-lineage-specific. For example, the anti-stem cell 
activity in anti-platelet serum was not absorbed out with thymocytes or macrophages 
from the same mouse strain but was removed by absorption with platelets. Absorption 
of each  antiserum  with  nonhemopoietic  mouse  tissues  such  as  brain,  kidney,  liver, 
and testis did not reduce anti-stem cell activity. Thus, each antiserum was shown to 
be tissue specific and species specific. Hemopoietic cells from mouse strains other than 
CBA absorbed out  most of the anti-stem cell activity indicating cell-lineage-specific 
antigens to be common to the mouse strains tested. 
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